These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9298173)

  • 1. Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma.
    Mastalerz L; Milewski M; Duplaga M; Nizankowska E; Szczeklik A
    Allergy; 1997 Sep; 52(9):895-900. PubMed ID: 9298173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia.
    Webb DR; Meltzer EO; Finn AF; Rickard KA; Pepsin PJ; Westlund R; Cook CK
    Ann Allergy Asthma Immunol; 2002 Apr; 88(4):385-90. PubMed ID: 11995670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset of therapeutic effect of fluticasone propionate aqueous nasal spray.
    Meltzer EO; Rickard KA; Westlund RE; Cook CK
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):286-91. PubMed ID: 11289326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
    Meltzer EO; Stahlman JE; Leflein J; Meltzer S; Lim J; Dalal AA; Prillaman BA; Philpot EE
    Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa.
    Hallén H; Enerdal J; Graf P
    Clin Exp Allergy; 1997 May; 27(5):552-8. PubMed ID: 9179430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis.
    Bronsky EA; Dockhorn RJ; Meltzer EO; Shapiro G; Boltansky H; LaForce C; Ransom J; Weiler JM; Blumenthal M; Weakley S; Wisniewski M; Field E; Rogenes P
    J Allergy Clin Immunol; 1996 Apr; 97(4):915-21. PubMed ID: 8655886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
    Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
    Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.
    Meltzer EO; Andrews C; Journeay GE; Lim J; Prillaman BA; Garris C; Philpot E
    Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis.
    DeWester J; Philpot EE; Westlund RE; Cook CK; Rickard KA
    Allergy Asthma Proc; 2003; 24(5):331-7. PubMed ID: 14619333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proof-of-concept study to assess the putative dose response to topical corticosteroid in persistent allergic rhinitis using adenosine monophosphate challenge.
    Barnes ML; Menzies D; Nair AR; Hopkinson PJ; Lipworth BJ
    Clin Exp Allergy; 2007 May; 37(5):696-703. PubMed ID: 17456217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and onset of action of fluticasone propionate aqueous nasal spray on nasal symptoms, eosinophil count, and mediator release after nasal allergen challenge in patients with seasonal allergic rhinitis.
    Wang D; Duyck F; Smitz J; Clement P
    Allergy; 1998 Apr; 53(4):375-82. PubMed ID: 9574879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
    Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
    J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal steroids improve regulation of nasal patency in asthma and mild rhinitis: a randomised, cross-over trial.
    Rimmer J; Greenwood A; Bartlett D; Hellgren J
    Eur Arch Otorhinolaryngol; 2012 Apr; 269(4):1133-8. PubMed ID: 22033572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
    Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis.
    Jordana G; Dolovich J; Briscoe MP; Day JH; Drouin MA; Gold M; Robson R; Stepner N; Yang W
    J Allergy Clin Immunol; 1996 Feb; 97(2):588-95. PubMed ID: 8621843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary efficacy of fluticasone delivered by a novel device in recalcitrant chronic rhinosinusitis.
    Hansen FS; Djupesland PG; Fokkens WJ
    Rhinology; 2010 Sep; 48(3):292-9. PubMed ID: 21038019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids.
    Wilson AM; Lipworth BJ
    Thorax; 1999 Jan; 54(1):20-6. PubMed ID: 10343626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis.
    Day J; Carrillo T
    J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):902-8. PubMed ID: 9847429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in nasal reactivity in patients with rhinitis medicamentosa after treatment with fluticasone propionate and placebo nasal spray.
    Graf PM; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1998; 60(6):334-8. PubMed ID: 9742282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.